1. Home
  2. ALLO vs GSM Comparison

ALLO vs GSM Comparison

Compare ALLO & GSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$2.17

Market Cap

738.4M

Sector

Health Care

ML Signal

HOLD

Logo Ferroglobe PLC

GSM

Ferroglobe PLC

HOLD

Current Price

$4.29

Market Cap

801.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLO
GSM
Founded
2017
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Metal Mining
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
738.4M
801.6M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
ALLO
GSM
Price
$2.17
$4.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
1
Target Price
$8.35
$6.00
AVG Volume (30 Days)
6.1M
1.2M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
1.34%
EPS Growth
34.09
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$23.36
Revenue Next Year
$142,416.42
$17.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.99
$3.51
52 Week High
$4.46
$5.74

Technical Indicators

Market Signals
Indicator
ALLO
GSM
Relative Strength Index (RSI) 48.92 50.91
Support Level $2.12 $4.08
Resistance Level $2.71 $4.49
Average True Range (ATR) 0.14 0.20
MACD 0.02 0.04
Stochastic Oscillator 57.27 67.83

Price Performance

Historical Comparison
ALLO
GSM

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).

About GSM Ferroglobe PLC

Ferroglobe PLC provides silicon-based alloys and specialty metals. It produces silicon metal and silicon and manganese-based alloy, serving customers in the specialty chemical, aluminum, solar, steel, and ductile iron foundry industries. The company's operating segments include Canada - Silicon Metals, Canada - Silicon Alloys, U.S. - Silicon Metals, U.S. - Silicon Alloys, Europe - Manganese Alloys, Europe - Silicon Metals, Europe - Silicon Alloys, South Africa - Silicon Metals, South Africa - Silicon Alloys, and Other segments. The primary raw materials the company uses to produce its electrometallurgy products include its coal and quartz mining operations and its silicon metal and ferroalloy production. The firm generates key revenue from Silicon metal and Manganese-based alloys.

Share on Social Networks: